Bibliography
Das, K., Ding, J., Hsiou, Y., Clark, A. D., Moereels, H., Koymans, L., Andries, K., Pauwels, R., Janssen, P. A. J., Boyer, P. L., Clark, P., Smith, R. H., Kroeger Smith, M. B., Michejda, C. J., Hughes, S. H., & Arnold, E. (1996). Crystal Structures of 8-Cl and 9-Cl TIBO Complexed with Wild-type HIV-1 RT and 8-Cl TIBO Complexed with the Tyr181Cys HIV-1 RT Drug-resistant Mutant. Journal of Molecular Biology, 264(5), 1085â1100.
Authors
16
- Kalyan Das (first)
- Jianping Ding (additional)
- Yu Hsiou (additional)
- Arthur D. Clark (additional)
- Henri Moereels (additional)
- Luc Koymans (additional)
- Koen Andries (additional)
- Rudi Pauwels (additional)
- Paul A.J. Janssen (additional)
- Paul L. Boyer (additional)
- Patrick Clark (additional)
- Richard H. Smith (additional)
- Marilyn B. Kroeger Smith (additional)
- Christopher J. Michejda (additional)
- Stephen H. Hughes (additional)
- Edward Arnold (additional)
References
61
Referenced
158
10.1038/357085a0
/ Nature / Structure of HIV-1 reverse transcriptase/DNA complex at 7 Å resolution showing active site locations by Arnold (1992){'key': '10.1006/jmbi.1996.0698_bib2', 'first-page': '29', 'article-title': 'Targeting HIV reverse transcriptase for anti-AIDS drug design', 'volume': '13', 'author': 'Arnold', 'year': '1996', 'journal-title': 'Drug Design Discov.'}
/ Drug Design Discov. / Targeting HIV reverse transcriptase for anti-AIDS drug design by Arnold (1996)10.1006/viro.1993.1027
/ Virology / HIV-1-specific reverse transcriptase inhibitors show differential activity against mutant strains containing different amino acid substitutions in the reverse transcriptase by Balzarini (1993)10.1128/JVI.67.9.5353-5359.1993
/ J. Virol. / Treatment of human immunodeficiency virus type 1 (HlV-l)-infected cells with combinations of HIV-1-specific inhibitors results in a different resistance pattern than does treatment with single-drug therapy by Balzarini (1993)10.1007/BF01209549
/ J. Cryst. Mol. Struct. / Identification of the configurational type of seven-membered rings by Boessenkool (1980)10.1128/AAC.38.9.1909
/ Antimicrob. Agents Chemother. / Drug resistance of human immunodeficiency virus type 1 reverse transcriptase: subunit specificity of mutations that confer resistance to nonnucleoside inhibitors by Boyer (1994)10.1038/355472a0
/ Nature / The free R value: a novel statistical quantity for assessing the accuracy of crystal structures by Brünger (1992){'key': '10.1006/jmbi.1996.0698_bib8', 'series-title': 'X-PLOR Manual version 3.1: a system for X-ray crystallography and NMR', 'author': 'Brtinger', 'year': '1993'}
/ X-PLOR Manual version 3.1: a system for X-ray crystallography and NMR by Brtinger (1993)10.1128/AAC.37.8.1576
/ Antimicrob. Agents Chemother. / Comprehensive mutant enzyme and viral variant assessment of human immunodeficiency virus type 1 reverse transcriptase resistance to nonnucleoside inhibitors by Byrnes (1993)10.1016/0263-7855(87)80010-3
/ J. Mol. Graph. / Ribbon models of macromolecules by Carson (1987)10.1016/0076-6879(95)62017-6
/ Methods Enzymol. / Crystallization of human immunodeficiency virus type 1 reverse transcriptase with and without nucleic acid substrates, inhibitors, and an antibody Fab fragment by Clark (1995)10.1107/S0907444994003112
/ Acta Crystallog. sect. D / The CCP4 suite: programs for protein crystallography (1994){'key': '10.1006/jmbi.1996.0698_bib13', 'first-page': '34', 'article-title': 'Dmmulti', 'volume': '31', 'author': 'Cowtan', 'year': '1994', 'journal-title': 'Joint CCP4 and ESF-EACBM Newsletter on Protein Crystallography'}
/ Joint CCP4 and ESF-EACBM Newsletter on Protein Crystallography / Dmmulti by Cowtan (1994)10.1016/0006-2952(94)90001-9
/ Biochem. Pharmacol. / HIV resistance to reverse transcriptase inhibitors by De Clercq (1994)10.1128/CMR.8.2.200
/ Clin. Microbiol. Rev. / Antiviral therapy of human immunodeficiency virus infections by De Clercq (1995)10.1021/jm00014a001
/ J. Med. Chem. / Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections by De Clercq (1995)10.1038/nsb0595-407
/ Nature Struct. Biol. / Structure of HIV-1 RT/TIBO R 86183 reveals similarity in the binding of diverse non-nucleoside inhibitors by Ding (1995)10.1016/S0969-2126(01)00168-X
/ Structure / Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor α-APA R 95845 at 2.8 Å resolution by Ding (1995)10.1073/pnas.90.10.4713
/ Proc. Natl Acad. Sci. USA / A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other non-nucleoside inhibitors by Dueweke (1993)10.1038/nsb0495-303
/ Nature Struct. Biol. / Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors by Esnouf (1995){'key': '10.1006/jmbi.1996.0698_bib21', 'series-title': 'Data Collection and Processing', 'first-page': '114', 'article-title': 'Data reduction', 'author': 'Evans', 'year': '1993'}
/ Data Collection and Processing / Data reduction by Evans (1993)10.1016/0076-6879(85)15021-4
/ Methods Enzymol. / Stereochemically restrained refinement of macromolecular structures by Hendrickson (1985)10.1038/373123a0
/ Nature / Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection by Ho (1995)10.1021/jm960056x
/ J. Med. Chem. / Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nu-cleoside inhibitors by Hopkins (1996)10.1016/S0969-2126(96)00091-3
/ Structure / Structure of unliganded human immunodeficiency virus type 1 reverse transcriptase at 2.7 Å resolution: implications of conformational changes for polymerization and inhibition mechanisms by Hsiou (1996)10.1073/pnas.90.13.6320
/ Proc. Natl Acad. Sci. USA / Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA by Jacobo-Molina (1993)10.1107/S0108767390010224
/ Acta Crystallog. sect. A / Improved methods for building protein models in electron density maps and the location of errors in these models by Jones (1991)10.1107/S0907444993011333
/ Acta Crystallog. sect. D. / Detection, delineation, measurement and display of cavities in macromolecular structures by Kleywegt (1994){'key': '10.1006/jmbi.1996.0698_bib29', 'series-title': 'From First Map to Final Model', 'first-page': '59', 'article-title': 'Halloween, masks and bones', 'author': 'Kleywegt', 'year': '1994'}
/ From First Map to Final Model / Halloween, masks and bones by Kleywegt (1994)10.1126/science.1377403
/ Science / Crystal structure at 3.5 Å resolution of HTV-1 reverse transcriptase complexed with an inhibitor by Kohlstaedt (1992)10.1128/AAC.36.12.2664
/ Antimicrob. Agents Chemother. / S'-Azido-S'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to non-nu-cleoside reverse transcriptase inhibitors by Larder (1992){'key': '10.1006/jmbi.1996.0698_bib32', 'series-title': 'Reverse Transcriptase', 'first-page': '205', 'article-title': 'Inhibitors of HIV reverse transcriptase as antiviral agents and drug resistance', 'author': 'Larder', 'year': '1993'}
/ Reverse Transcriptase / Inhibitors of HIV reverse transcriptase as antiviral agents and drug resistance by Larder (1993)10.1021/ja00005a075
/ J. Am. Chem. Soc. / Molecular structure of a potent HIV-1 inhibitor belonging to TIBO family by Liaw (1991){'key': '10.1006/jmbi.1996.0698_bib34', 'series-title': 'XDISPLAYF program', 'author': 'Minor', 'year': '1993'}
/ XDISPLAYF program by Minor (1993)10.1007/BF02171659
/ Perspect. Drug Discov. Design / Review of HIV-1 reverse transcriptase three-dimensional structure: implications for drug design by Nanni (1993)10.1128/JVI.65.9.4887-4892.1991
/ J. Virol. / Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors by Nunberg (1991){'key': '10.1006/jmbi.1996.0698_bib37', 'series-title': 'Data Collection and Processing', 'first-page': '55', 'article-title': 'Oscillation data reduction program', 'author': 'Otwinowski', 'year': '1993'}
/ Data Collection and Processing / Oscillation data reduction program by Otwinowski (1993)10.1073/pnas.90.5.1711
/ Proc. Natl Acad. Sci. USA / Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of a-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase by Pauwels (1993)10.1128/AAC.38.12.2863
/ Antimicrob. Agents Chemother. / New TIBO derivatives are potent inhibitors of HIV-1 replication and are synergistic with 2′,3′-dideoxynucleoside analogues by Pauwels (1994)10.1107/S0108767386099622
/ Acta Crystallog. sect. A / Improved Fourier coefficients or maps using phases from partial structures with errors by Read (1986)10.1038/nsb0495-293
/ Nature Struct. Biol. / High resolution structures of HIV-1 RT from four RT-inhibitor complexes by Ren (1995)10.1016/S0969-2126(01)00226-X
/ Structure / The structure of HIV-1 reverse transcriptase complexed with 9-chloro-TIBO: lessons for inhibitor design by Ren (1995)10.1128/AAC.37.6.1207
/ Antimicrob. Agents Chemother. / Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents by Richman (1993)10.1073/pnas.88.24.11241
/ Proc. Natl Acad. Sci. USA / Human immunodeficiency virus type 1 mutants resistant to non-nucleoside inhibitors of reverse transcriptase arise in tissue culture by Richman (1991)10.1128/JVI.68.3.1660-1666.1994
/ J. Virol. / Nevirapine resistance mutations of HIV-1 selected during therapy by Richman (1994)10.1073/pnas.92.17.8046
/ Proc. Natl Acad. Sci. USA / Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by non-nucleoside inhibitors by Rittinger (1995)10.1016/S0969-2126(94)00116-2
/ Structure / Cryocrystallography by Rodgers (1994)10.1073/pnas.92.4.1222
/ Proc. Natl Acad. Sci. USA / The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1 by Rodgers (1995){'key': '10.1006/jmbi.1996.0698_bib49', 'series-title': 'Anti-Pnfec-tives: Recent Advances in Chemistry and Structure Activity Relationships', 'article-title': 'Current perspectives on mechanisms of HIV-1 reverse transcriptase inhibition by nonnucleoside inhibitors', 'author': 'Sarafianos', 'year': '1996'}
/ Anti-Pnfec-tives: Recent Advances in Chemistry and Structure Activity Relationships / Current perspectives on mechanisms of HIV-1 reverse transcriptase inhibition by nonnucleoside inhibitors by Sarafianos (1996)10.1016/S0021-9258(19)37074-7
/ J. Biol. Chem. / Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple non-nucleoside inhibitors by Sardana (1992)10.1007/BF02171660
/ Per-spec. Drug Discov. Design / Competitive inhibitors of human immunodeficiency virus reverse transcriptase by Schinazi (1993)10.1073/pnas.91.9.3911
/ Proc. Natl Acad. Sci. USA / Structure of the binding site for non-nucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1 by Smerdon (1994)10.1002/pro.5560041026
/ Protein Sci. / Molecular modeling studies of HTV-1 reverse transcriptase non-nucleoside inhibitors: total energy of complexation as a predictor of drug placement and activity by Smith (1995)10.1126/science.7532321
/ Science / Mechanism of inhibition of reverse transcriptase by non-nucleoside inhibitors by Spence (1995)10.1021/bi952058+
/ Biochemistry / HIV-1 reverse transcriptase resistance to non-nucleoside inhibitors by Spence (1996)10.1016/S1046-2023(05)80145-8
/ Methods / Analytical and production seeding techniques by Stura (1990)10.1006/jmbi.1994.1665
/ J. Mol. Biol. / Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase: implications for mechanisms of drug inhibition and resistance by Tantillo (1994)10.1107/S0021889890005568
/ J. Appl. Crystallog. / Mounting of crystals for macromolecu-lar crystallography in a free-standing thin film by Teng (1990)10.1089/aid.1994.10.39
/ AIDS Res. Human Retro. / Characterization of HIV-1 strains isolated from patients treated with TIBO R82913 by Vandamme (1994)10.1038/373117a0
/ Nature / Viral dynamics in human immunodeficiency virus type 1 infection by Wei (1995)10.1007/BF02171661
/ Perspect. Drug Discov. Design / Non-nucleoside inhibitors of HIV-1 reverse transcriptase by Young (1993)
Dates
Type | When |
---|---|
Created | 22 years, 10 months ago (Oct. 7, 2002, 7:21 a.m.) |
Deposited | 4 years, 3 months ago (May 3, 2021, 6:01 a.m.) |
Indexed | 2 months, 3 weeks ago (June 6, 2025, 5:08 a.m.) |
Issued | 28 years, 9 months ago (Dec. 1, 1996) |
Published | 28 years, 9 months ago (Dec. 1, 1996) |
Published Print | 28 years, 9 months ago (Dec. 1, 1996) |
@article{Das_1996, title={Crystal Structures of 8-Cl and 9-Cl TIBO Complexed with Wild-type HIV-1 RT and 8-Cl TIBO Complexed with the Tyr181Cys HIV-1 RT Drug-resistant Mutant}, volume={264}, ISSN={0022-2836}, url={http://dx.doi.org/10.1006/jmbi.1996.0698}, DOI={10.1006/jmbi.1996.0698}, number={5}, journal={Journal of Molecular Biology}, publisher={Elsevier BV}, author={Das, Kalyan and Ding, Jianping and Hsiou, Yu and Clark, Arthur D. and Moereels, Henri and Koymans, Luc and Andries, Koen and Pauwels, Rudi and Janssen, Paul A.J. and Boyer, Paul L. and Clark, Patrick and Smith, Richard H. and Kroeger Smith, Marilyn B. and Michejda, Christopher J. and Hughes, Stephen H. and Arnold, Edward}, year={1996}, month=dec, pages={1085–1100} }